1887

Abstract

Nucleoside analogues may represent good candidates for the discovery of new antibacterial agents, therefore, a library of adenosine analogues was assessed for their antibacterial activity, and the relationship between the structure and activity of these molecules was outlined. Antibacterial activity was evaluated against that of reference strains of , , , and . We tested 54 adenosine analogues, modified both at ribose and base moieties, including adenine and 1/3-deazaadenine derivatives substituted in the 2- and/or -positions and bearing -9 sugar moieties, such as ribose, 2′-deoxyribose, 3′-deoxyribose, 2′,3′-dideoxyribose or cycloalkyl groups like cyclopentane. The data obtained, MIC and minimal bactericidal concentrations demonstrated that the presence of bulky substituents such as cycloheptyl and cyclooctyl rings on the -amino, together with a chlorine atom in the 2-position, conferred antibacterial activity against the Gram-positive group with MIC values ranging from 16 to 128 mg l. The intact sugar moiety seemed to be not essential for antimicrobial activity and nucleosides bearing deoxyribose or cyclopentyl groups associated with bulky substituents in -position showed good antimicrobial properties. Furthermore, -1 proved to be non-crucial and the 2-chloro- -cyclooctyl-1-deaza-3′-deoxyadenosine and 2′,3′-dideoxyadenosine compounds were among the more active in the series with an MIC of 32 mg l against and . None of the analogues was active against the two Gram-negative species tested. Hence, adenosine derivatives bearing bulky substituents in the -position may represent good lead compounds for the future discovery of a novel series of antibacterial agents.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.038174-0
2012-04-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/4/525.html?itemId=/content/journal/jmm/10.1099/jmm.0.038174-0&mimeType=html&fmt=ahah

References

  1. Ahn Y. J., Park S. J., Lee S. G., Shin S. C., Choi D. H. 2000; Cordycepin: selective growth inhibitor derived from liquid culture of Cordyceps militaris against Clostridium spp.. J Agric Food Chem 48:2744–2748 [View Article][PubMed]
    [Google Scholar]
  2. Bzowska A., Kulikowska E., Shugar D. 2000; Purine nucleoside phosphorylases: properties, functions, and clinical aspects. Pharmacol Ther 88:349–425 [View Article][PubMed]
    [Google Scholar]
  3. CLSI 2009; Performance standards for antimicrobial susceptibility testing, 19th informational supplement, M100–S19. Wayne, PA: Clinical and Laboratory Standards Institute;
  4. Cristalli G., Vittori S., Eleuteri A., Volpini R., Camaioni E., Lupidi G., Mahmood N., Bevilacqua F., Palù G. 1995; Synthesis and biological evaluation of N 6-cycloalkyl derivatives of 1-deazaadenine nucleosides: a new class of anti-human immunodeficiency virus agents. J Med Chem 38:4019–4025 [View Article][PubMed]
    [Google Scholar]
  5. ECDC 2010; Antimicrobial resistance surveillance in Europe 2009. In Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) . Stockholm: European Centre for Disease Prevention and Control; Available online http://ecdc.europa.eu/en/publications/Publications/1011_SUR_annual_EARS_Net_2009.pdf
  6. Isono K. 1988; Nucleoside antibiotics: structure, biological activity, and biosynthesis. J Antibiot (Tokyo) 41:1711–1739[PubMed] [CrossRef]
    [Google Scholar]
  7. Kimura K., Bugg T. D. H. 2003; Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis. Nat Prod Rep 20:252–273 [View Article][PubMed]
    [Google Scholar]
  8. Mills S. D., Eakin A. E., Buurman E. T., Newman J. V., Gao N., Huynh H., Johnson K. D., Lahiri S., Shapiro A. B. other authors 2011; Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo . Antimicrob Agents Chemother 55:1088–1096 [View Article][PubMed]
    [Google Scholar]
  9. Salvatori D., Volpini R., Vincenzetti S., Vita A., Costanzi S., Lambertucci C., Cristalli G., Vittori S. 2002; Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1. Bioorg Med Chem 10:2973–2980 [View Article][PubMed]
    [Google Scholar]
  10. Shimada N., Hasegawa S., Harada T., Tomisawa T., Fujii A., Takita T. 1986; Oxetanocin, a novel nucleoside from bacteria. J Antibiot (Tokyo) 39:1623–1625[PubMed] [CrossRef]
    [Google Scholar]
  11. Tunçbilek M., Ateş-Alagöz Z., Altanlar N., Karayel A., Özbey S. 2009; Synthesis and antimicrobial evaluation of some new substituted purine derivatives. Bioorg Med Chem 17:1693–1700 [View Article][PubMed]
    [Google Scholar]
  12. Vittori S., Lorenzen A., Stannek C., Costanzi S., Volpini R., IJzerman A. P., Kunzel J. K. V. F. D., Cristalli G. 2000; N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A1 adenosine receptor. J Med Chem 43:250–260 [View Article][PubMed]
    [Google Scholar]
  13. Vittori S., Dal Ben D., Lambertucci C., Marucci G., Volpini R., Cristalli G. 2006; Antiviral properties of deazaadenine nucleoside derivatives. Curr Med Chem 13:3529–3552 [View Article][PubMed]
    [Google Scholar]
  14. Volpini R., Camaioni E., Costanzi S., Vittori S., Cristalli G. 1998; Synthesis of new 3′-deoxyribonucleosides employing the acid-catalyzed fusion method. Helv Chim Acta 81:2326–2331 [View Article]
    [Google Scholar]
  15. Volpini R., Costanzi S., Vittori S., Cristalli G., Lupidi G. 1999; Synthesis and adenosine deaminase inhibitory activity of 3′-deoxy-1-deazaadenosines. Helv Chim Acta 82:2112–2118 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.038174-0
Loading
/content/journal/jmm/10.1099/jmm.0.038174-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error